Followers | 283 |
Posts | 1162 |
Boards Moderated | 0 |
Alias Born | 10/04/2020 |
Wednesday, October 14, 2020 8:36:37 PM
(conservative estimates only)
1). News Merger official: $0.25 - $1.0
PLUS:
2). News Funding official: $1.5 - $4.50
PLUS:
3). News BigPharma Partner named for commercialization: $5.00 - $6.00
PLUS:
4). Patient Clinical Trials underway Phase I-IV: $7 - $10.
PLUS:
5). Commercialization (pre earnings): $12 - $20
Please keep in mind CytoDyn's 52 week run was $0.52 to $10 not long ago under similar circumstances, has an inferior Monoclonal Ab Patent as previously discussed here, is currently trading in $3 range, and still has not reached market., no sales, no earnings!
All feedback welcome, and again, this is only speculation.
Be well and prosper ...
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
FEATURED Element79 Gold Corp Continues Fostering Local Community Engagement • Jun 4, 2024 9:08 AM
PickleJar Debuts Nationwide Contest With Brian Kelley for Fans to Win a Three-Day Bahama Cruise • NREG • Jun 3, 2024 8:45 AM
ILUS Provides an Update on the Binding Term Sheet Signed with Actelis Networks (NASDAQ: ASNS) • ILUS • May 31, 2024 12:52 PM
Element79 Gold To Provide Summary and Update on Active Exploration Program, Community Relations at RMEC on June 4 • ELEM • May 30, 2024 1:18 PM
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM
ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM